Michel Pavic

4.5k total citations
96 papers, 901 citations indexed

About

Michel Pavic is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Michel Pavic has authored 96 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 20 papers in Surgery. Recurrent topics in Michel Pavic's work include Multiple Myeloma Research and Treatments (12 papers), Cancer survivorship and care (11 papers) and Sarcoidosis and Beryllium Toxicity Research (9 papers). Michel Pavic is often cited by papers focused on Multiple Myeloma Research and Treatments (12 papers), Cancer survivorship and care (11 papers) and Sarcoidosis and Beryllium Toxicity Research (9 papers). Michel Pavic collaborates with scholars based in France, Canada and United States. Michel Pavic's co-authors include P. Debourdeau, P. Sève, H Rousset, Éléonor Riesco, Tamás Fülöp, Dominique Farge, A. Bérezné, C. Broussolle, Claire Fieschi and Marion Malphettes and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Michel Pavic

89 papers receiving 883 citations

Peers

Michel Pavic

PRM

ONCOL

PHYSI

IMMUN

Alessandro Tomelleri Italy

Aengus O’Marcaigh Ireland

Canan Akyüz Türkiye

M. García García Spain

Dominique Desvaux France

James N. Butera United States

Stéphan Pavy France

Benjamin Chaigne France

Raquel Ríos-Fernández Spain

Joichi Usui Japan

Alessandro Tomelleri Italy

Michel Pavic

547 ×2.0

PRM

109 ×0.5

ONCOL

199 ×1.0

PHYSI

185 ×1.0

IMMUN

191 ×1.3

Citations per year, relative to Michel Pavic Michel Pavic (= 1×) peers Alessandro Tomelleri

Countries citing papers authored by Michel Pavic

Since Specialization

Citations

This map shows the geographic impact of Michel Pavic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Pavic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Pavic more than expected).

Fields of papers citing papers by Michel Pavic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Pavic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Pavic. The network helps show where Michel Pavic may publish in the future.

Co-authorship network of co-authors of Michel Pavic

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Pavic. A scholar is included among the top collaborators of Michel Pavic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Pavic. Michel Pavic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suvannasankha, Attaya, Jonathan L. Kaufman, Ashraf Badros, et al.. (2025). Safety and efficacy of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma: Results from the phase 1b MagnetisMM-30 trial. Blood. 146(Supplement 1). 100–100.

Tremblay, Dominique, Marie‐Claude Battista, Djamal Berbiche, et al.. (2025). Telehomecare Monitoring for Patients Receiving Anticancer Oral Therapy: Protocol for a Mixed Methods Evaluability Study. JMIR Research Protocols. 14. e63099–e63099. 1 indexed citations

Leblanc, Richard, Jean Roy, Julie Anne Côté, et al.. (2024). Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia. Cancer Medicine. 13(17). e70192–e70192. 1 indexed citations

McFadden, Nathalie, et al.. (2024). Cancer population norms using a new value set for the SF-6Dv2 based on the preferences of patients with breast or colorectal cancer in Quebec. Quality of Life Research. 33(6). 1605–1619. 1 indexed citations

Wong, Philip, Laura Masucci, Marie Florescu, et al.. (2023). Phase II multicenter trial combining nivolumab and radiosurgery for NSCLC and RCC brain metastases. Neuro-Oncology Advances. 5(1). vdad018–vdad018. 11 indexed citations

Pavic, Michel, et al.. (2023). Second Version of the Short Form 6-Dimension Value Set Elicited From Patients With Breast and Colorectal Cancer. Medical Care. 61(8). 536–545. 7 indexed citations

LeBlanc, Richard, Jean Roy, Marc Lalancette, et al.. (2023). Primary or Secondary Plasma Cell Leukemia: Dismal Outcome Despite Modern Treatments. Blood. 142(Supplement 1). 3399–3399. 1 indexed citations

Tai, Lee‐Hwa, et al.. (2023). Acute Nk Cells Response To Different Aerobic Exercise Modalities In Metastatic Cancer Patients Undergoing Chemotherapy. Medicine & Science in Sports & Exercise. 55(9S). 479–479. 1 indexed citations

Wagner, J. Richard, et al.. (2019). Effects of combined exercise training on the inflammatory profile of older cancer patients treated with systemic therapy. Brain Behavior & Immunity - Health. 2. 100016–100016. 11 indexed citations

10.

Foucaut, Aude-Marie, et al.. (2016). Activité physique et cancer. Hématologie. 22(5). 333–343. 1 indexed citations

11.

Grados, A., Mikaël Ebbo, E. Bernit, et al.. (2015). Sarcoidosis Occurring After Solid Cancer. Medicine. 94(28). e928–e928. 36 indexed citations

12.

Moigne, François Le, et al.. (2012). Infarctus rénal veineux, une complication de l’hémoglobinurie paroxystique nocturne. Néphrologie & Thérapeutique. 8(7). 537–539. 2 indexed citations

13.

Bergmann, Carsten, et al.. (2012). Une cause rare de douleurs abdominales. La Revue de Médecine Interne. 33(10). 593–594. 1 indexed citations

14.

Debourdeau, P., Grégoire Le Gal, Irène Kriegel, et al.. (2009). 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Annals of Oncology. 20(9). 1459–1471. 95 indexed citations

15.

Pasquet, F., et al.. (2008). L’érythème flagellé : une complication rare de la bléomycine. La Revue de Médecine Interne. 30(7). 637–639. 3 indexed citations

16.

Pasquet, F., et al.. (2008). Une complication rare de la gastroscopie. La Revue de Médecine Interne. 29(10). 823–824. 1 indexed citations

17.

Pavic, Michel, et al.. (2007). Granulomatoses systémiques pseudosarcoïdosiques d’étiologie déterminée et non tuberculeuse. Étude de 67 observations. La Revue de Médecine Interne. 29(1). 5–14. 9 indexed citations

18.

Pavic, Michel, et al.. (2007). Place de la pathologie granulomateuse au cours des cancers. La Revue de Médecine Interne. 29(1). 39–45. 39 indexed citations

19.

Pavic, Michel, P. Debourdeau, M. Aletti, Dominique Farge, & H Rousset. (2005). Maladie veineuse thromboembolique et cancer. La Revue de Médecine Interne. 27(4). 313–322. 9 indexed citations

20.

Pavic, Michel, P. Petiot, Nathalie Streichenberger, et al.. (2003). Maladie de Mac Ardle diagnostiquée après 30 ans : à propos de 12 cas. La Revue de Médecine Interne. 24(11). 716–720. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact